Philadelphia, PA - Olfactory Biosciences Corp. (OLFC) the makers of NOXO Autism Aid(TM) herald the recent success of their Autism balm. NOXO’s innovation is making Autism Respite Care less stressful for Autistic individuals and caregivers while improving the quality of life for their parents.
NOXO Autism Aid(TM) reduces the frequency and intensity of coping behaviors, odor fixations and overstimulation from environmental irritants. Providing parents with piece of mind while their child is in respite care.
NOXO Autism Aid(TM) is similar to a lip balm but is applied just below the nostrils on the upper lip. Allowing the natural formula to be inhaled and take effect. NOXO’s solution is safe, easy to apply and non-invasive. It works on your body’s natural processes and responses. It is the first product to address behavioral issues triggered by sensitivities.
Respite owners, Todd and Margaret (INKA) of InkaRespite have been able to improve the quality of their Autistic visitors stay, "I ordered NOXO balm from your webpage and it has worked wonders. It completely stopped this attraction to odours as well as reducing many other self-stimulation behaviours. My husband and I live in Australia and have a farm which we use as a respite camp for children with Autism Spectrum Disorder. We have used NOXO for other children at the camp as well who are sensitive to certain smells. Parents purchase NOXO balm for themselves to use at home and school."
Experts say NOXO Autism Aid(TM) can also be applied to children or adults with ADD, ADHD, Down syndrome, fragile X, prematurity, and fetal alcohol syndrome who manifest behavioral issues.
You can get more information on NOXO Autism Aid(TM) at http://www.noxoinfo.com/autism.html or buy now!
About Olfactory Biosciences Corp
Olfactory Biosciences Corp.’s NOXO division is focused to develop a variety of products targeting Olfactory Receptors for the desired effect. These alternative medicine wellness products may modify behavior or provide relief to common behavior challenges such as anxiety, smoking or weight control, as examples.
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements by the Company, statements regarding the NOXO product line, optimism related to the business, expanding ales and other statements in this press release are forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Such statements are based on current expectations, estimates and projections about the Company's business. Words such as expects, anticipates, intends, plans, believes, sees, estimates and variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks and uncertainties that are difficult to predict. Actual results could vary materially from the description contained herein due to many factors including continued market acceptance of the Company's products or the need to raise additional capital. In addition, actual results could vary materially based on changes or slower growth in the indoor garden market; the potential inability to realize expected benefits and synergies; domestic and international business and economic conditions; changes in customer demand or ordering patterns; changes in the competitive environment including pricing pressures or technological changes; technological advances; shortages of manufacturing capacity; future production variables impacting excess inventory and other risk factors listed from time to time in the Company's Securities and Exchange Commission (SEC) filings under "risk factors" and elsewhere. The forward-looking statements contained in this press release speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this press release.
Richard Stevenson, President
Olfactory Biosciences Corp.
333 E. Lancaster Ave. Suite 317
Wynnewood, PA 19096, USA
Source: Olfactory Biosciences Corp.
Leave a comment...